Replies to post #79732 on Enzolytics Inc (ENZC)

[Jisep]

Is that the news that the COO of ENZC tweeted yesterday?

[Lelelelelawl]

I understand about half of the words on that but I assume it is very good from what I understand in it because if they get a patent on that most major companies will be looking to Enzolytics for information covered by the patents, I think.

[bytheocean]

That's a great PR.

There are so many great parts, but here is one part I really like. It reports their continued efforts to basically create and patent therapies for some of the biggest viruses on earth:

"Using AI analysis, the Company is now identifying and will claim the conserved epitopes/antigens on the infectious diseases caused by HIV-2, Influenza A and B, H1N1 influenza, Respiratory syncytial virus (RSV), Small-Pox, Ebola Virus, Tetanus, Diphtheria, HTLV-1/2, Rabies, Herpes zoster, Varicella zoster, Anthrax, Mason-Pfizer monkey virus (MPMV), Visna virus (VISNA) and mouse mammary tumor virus (MMTV). Patent applications will be filed claiming the inventive findings. Patent claims will cover the discovered epitope/antigens, with proposed vaccine claims, antibody claims, and related prophylactic/therapeutic method claims relating to these identified epitope/antigens.

In addition to the AI analysis, the Company is applying its proprietary methodology for producing fully human monoclonal antibodies targeting these identified epitope sites on the various viruses curated. The significance of producing multiple monoclonal antibodies targeting multiple conserved sites is recognized by experts as a critical approach to effective therapy. This allows the administration of a "cocktail" of antibodies, all targeting conserved and expectedly immutable sites."